In addition, AerBetic was recognized as one of the “10 CES 2019 gadgets for forward-thinking first responders” by FireRescue1 and EMS1.com. Smithsonian Magazine also recognized AerBetic as one of the “Seven Unforgettable Inventions Unveiled at This Year’s CES.”

“We were blown away by the reception we received at CES, from industry partners, to the media, to the people who sought us out because they are personally affected by diabetes,” said AerBetic CEO and entrepreneur Arnar Thors.

“The universal positive feedback reaffirmed to us that our mission with AerBetic is a vital and important one. We’re now looking forward on capitalizing on our momentum and continuing to drive toward delivering this product.”

The device was inspired by Thors’ family pet, a yellow lab that came from a place that also trains alert animals. Many diabetics rely on specially trained dogs to detect increases in Volatile Organic Compounds in their exhaled breath; AerBetic’s device will detect the same gas patterns.

ATTRACTING INTEREST

AerBetic also participated in CES Unveiled, a media-only event featuring a select group of exhibitors. During the event, company officials shared the AerBetic story with several dozen news outlets and stakeholders, including the National Institutes of Health (NIH), the American Association of Retired Persons (AARP) and others.

Following the event, AerBetic was featured in Wired Magazine, CNBC, Techlicious, Clark Howard, KNTV Las Vegas, and others.

During the show, AerBetic attracted interest from numerous potential partners, investors and supporters. Visiting companies included Apple, Samsung, FitBit, Google, Timex, Amazon, Best Buy, Sam’s Club/Walmart, Target and others.

Company officials say the positive attention prompted a huge spike in web traffic and worldwide interest in the beta testing phase.

Testing for AerBetic’s device is expected to begin in the first quarter of this year, with the first production units scheduled to ship late this year or early next year.